Skip to content

Clinical trials

Multiple Sclerosis, Relapsing-Remitting trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis, Relapsing-Remitting Country / region: Sweden Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20062
20073
20081
20092
20102
20133
20143
20151
20162
20172
20181
20201
20211
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated7
Active, not recruiting3
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen8
Genzyme, a Sanofi Company5
Bayer3
Uppsala University3
Hoffmann-La Roche2
Karolinska Institutet2
Amgen1
Anders Svenningsson1
GlaxoSmithKline1
Grifols Therapeutics LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis, Relapsing-Remitting30
Multiple Sclerosis10
Autoimmune Diseases1
Demyelinating Diseases1
Disease Progression1
Fatigue1
Immune System Diseases1
Multiple Sclerosis, Chronic Progressive1
Nervous System Diseases1

Trials

Showing 51 to 30 of 30. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.